Introduction to Chemotherapy Induced Anemia Study
The Cancer Patients have innately low erythromycin levels, and especially those receiving chemotherapy or radiation therapy exhibit a higher frequency of anemia. Advance Research Development Solution provide quality medical research for enrolling studies. For Chemotherapy Induced Anemia study, the patients have to be:
- Subjects (male or female) ≥ 18 years of age able to give informed consent to the study
- Subjects whose cancer treatment is considered non-curative
- Subjects with solid tumors that have metastasized
- Receiving non-adjuvant chemotherapy as part of their cancer treatment With at least 2 cycles remaining
Iron Deficiency Anemia in Cancer Patients Receiving Chemotherapy
- Screening visit central laboratory hemoglobin (Hgb) <11 g/dL, but ≥ 8 g/dL
- Ferritin between 100 and 800 ng/mL and transferrin saturation (TSAT) ≤ 25%
- Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 2
Register Here or Call: 786 615 7132
Comments or questions are welcome.
- Life expectancy of at least 6 months.
- Demonstrate the ability to understand the requirements of the study, willingness to abide by study restrictions and to return for the required assessments.
All study-related medical care, labs tests and investigation study medicine will be provided at no cost to you.
You may receive compensation for time and travel.